Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

Clinical trial NCT06033092 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06033092
Sponsor: European Institute of Oncology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

BRCA Mutation PALB2 Gene Mutation Ductal Carcinoma in Situ Lobular Carcinoma in Situ ATM Gene Mutation CHEK2 Gene Mutation CDH1 Gene Mutation RAD51C Gene Mutation RAD51D Gene Mutation

Start date: 2024-06-21
Primary completion: 2025-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.